F. HANDAYANI, N. FITRIA, Y. O. SARI, and A. A., “IMPACT OF THE COMBINATION OF DOXORUBICIN, CYCLOPHOSPHAMIDE, AND DOCETAXEL ON CA 15-3 BIOMARKER LEVELS IN BREAST CANCER PATIENTS: A COMPARATIVE STUDY BETWEEN DELAYED AND NON-DELAYED CHEMOTHERAPY”, Int J App Pharm, vol. 17, no. 1, pp. 82–88, Feb. 2025.